Catalyst Wire Dossier Catalyst Wire Dossier

Dorzolamide and Timolol

Dorzolamide hydrochloride and timolol maleate ophthalmic solution · Leading Pharma, LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Dorzolamide and Timolol, covering 2024-02-20 to 2025-05-27. Get the full timeline:

Most recent: FDA Approved: DORZOLAMIDE AND TIMOLOL — Supplemental Application (Leading Pharma, LLC)

See pricing